BCR and chronic myelogenous leukemia, BCR-ABL1 positive: This is the first report of a CML patient with an atypical e19a2 BCR::ABL1 transcript and T315I mutation in whom treatment with asciminib resulted in stable complete molecular remission with five log PCR sensitivity (MR5).